Evaluation of Treatment With Zemplar Capsules in the Therapy of Secondary Hyperparathyroidism (SHPT)
Clinical trial NCT01224782 · COMPLETED
Trial details
- NCT number
- NCT01224782
- Sponsor
- AbbVie (prior sponsor, Abbott)
- Status
- COMPLETED
- Study type
- OBSERVATIONAL
- Start date
- 2010-10-01
- Primary completion
- 2013-08-01
- Enrollment
- 994
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.